79 related articles for article (PubMed ID: 8016309)
1. Reductions of 56Fe heavy-particle irradiation-induced deficits in striatal muscarinic receptor sensitivity by selective cross-activation/inhibition of second-messenger systems.
Joseph JA; Villalobos-Molina R; Rabin BM; Dalton TK; Harris A; Kandasamy S
Radiat Res; 1994 Jul; 139(1):60-6. PubMed ID: 8016309
[TBL] [Abstract][Full Text] [Related]
2. Deficits in the sensitivity of striatal muscarinic receptors induced by 56Fe heavy-particle irradiation: further "age-radiation" parallels.
Joseph JA; Hunt WA; Rabin BM; Dalton TK; Harris AH
Radiat Res; 1993 Aug; 135(2):257-61. PubMed ID: 8367598
[TBL] [Abstract][Full Text] [Related]
3. Iron-56 irradiation diminishes muscarinic but not alpha 1-adrenergic-stimulated low-Km GTPase in rat brain.
Villalobos-Molina R; Joseph JA; Rabin BM; Kandasamy SB; Dalton TK; Roth GS
Radiat Res; 1994 Dec; 140(3):382-6. PubMed ID: 7972691
[TBL] [Abstract][Full Text] [Related]
4. Magnesium activation of GTP hydrolysis or incubation in S-adenosyl-l-methionine reverses iron-56-particle-induced decrements in oxotremorine enhancement of K+-evoked striatal release of dopamine.
Joseph JA; Shukitt-Hale B; McEwen J; Rabin B
Radiat Res; 1999 Dec; 152(6):637-41. PubMed ID: 10581534
[TBL] [Abstract][Full Text] [Related]
5. Selective cross-activation/inhibition of second messenger systems and the reduction of age-related deficits in the muscarinic control of dopamine release from perifused rat striata.
Joseph JA; Kowatch MA; Maki T; Roth GS
Brain Res; 1990 Dec; 537(1-2):40-8. PubMed ID: 1964841
[TBL] [Abstract][Full Text] [Related]
6. Possible "accelerated striatal aging" induced by 56Fe heavy-particle irradiation: implications for manned space flights.
Joseph JA; Hunt WA; Rabin BM; Dalton TK
Radiat Res; 1992 Apr; 130(1):88-93. PubMed ID: 1561322
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic potentiation of excitatory amino acid-evoked dopamine release in mesencephalic cells: specificity for the NMDA response and role of intracellular messengers.
Allaoua H; Chaudieu I; Alonso R; Quirion R; Boksa P
Synapse; 1993 Sep; 15(1):39-47. PubMed ID: 8310424
[TBL] [Abstract][Full Text] [Related]
8. Alterations in muscarinic control of striatal dopamine autoreceptors in senescence: a deficit at the ligand-muscarinic receptor interface?
Joseph JA; Dalton TK; Roth GS; Hunt WA
Brain Res; 1988 Jun; 454(1-2):149-55. PubMed ID: 3136856
[TBL] [Abstract][Full Text] [Related]
9. Age-related decrements in the muscarinic enhancement of K+-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence.
Joseph JA; Dalton TK; Hunt WA
Brain Res; 1988 Jun; 454(1-2):140-8. PubMed ID: 2900662
[TBL] [Abstract][Full Text] [Related]
10. Role of muscarinic receptors, G-proteins, and intracellular messengers in muscarinic modulation of NMDA receptor-mediated synaptic transmission.
Aramakis VB; Bandrowski AE; Ashe JH
Synapse; 1999 Jun; 32(4):262-75. PubMed ID: 10332802
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic cholinergic agonists stimulate arachidonic acid release from mouse striatal neurons in primary culture.
Tencé M; Cordier J; Premont J; Glowinski J
J Pharmacol Exp Ther; 1994 May; 269(2):646-53. PubMed ID: 8182531
[TBL] [Abstract][Full Text] [Related]
12. Decrement of muscarinic receptor-stimulated low-KM GTPase in striatum and hippocampus from the aged rat.
Yamagami K; Joseph JA; Roth GS
Brain Res; 1992 Apr; 576(2):327-31. PubMed ID: 1515926
[TBL] [Abstract][Full Text] [Related]
13. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
Ladner CJ; Lee JM
Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
[TBL] [Abstract][Full Text] [Related]
14. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
Lee NH; Geoghagen NS; Cheng E; Cline RT; Fraser CM
Mol Pharmacol; 1996 Jul; 50(1):140-8. PubMed ID: 8700106
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic receptor concentrations and dopamine release in aged rat striata.
Yamagami K; Joseph JA; Roth GS
Neurobiol Aging; 1992; 13(1):51-6. PubMed ID: 1542381
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of striatal GTPase and dopamine release responses to muscarinic cholinergic agonists in F344 rats: influence of age and dietary manipulation.
Kelly JF; Joseph JA; Denisova NA; Erat S; Mason RP; Roth GS
J Neurochem; 1995 Jun; 64(6):2755-64. PubMed ID: 7760056
[TBL] [Abstract][Full Text] [Related]
17. Spatial reference- (not working- or procedural-) memory performance of aged rats in the water maze predicts the magnitude of sulpiride-induced facilitation of acetylcholine release by striatal slices.
Cassel JC; Lazaris A; Birthelmer A; Jackisch R
Neurobiol Aging; 2007 Aug; 28(8):1270-85. PubMed ID: 16843572
[TBL] [Abstract][Full Text] [Related]
18. Developmental changes in presynaptic muscarinic modulation of excitatory and inhibitory neurotransmission in rat piriform cortex in vitro: relevance to epileptiform bursting susceptibility.
Whalley BJ; Constanti A
Neuroscience; 2006 Jul; 140(3):939-56. PubMed ID: 16616427
[TBL] [Abstract][Full Text] [Related]
19. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
20. In vitro effects of organophosphorus anticholinesterases on muscarinic receptor-mediated inhibition of acetylcholine release in rat striatum.
Liu J; Chakraborti T; Pope C
Toxicol Appl Pharmacol; 2002 Jan; 178(2):102-8. PubMed ID: 11814330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
